| ACTB | Actin beta |
| AGEs | Advanced glycation end-products |
| ANOVA | One-way analysis of variance |
| CAT | Catalase |
| cDNA | Complementary DNA |
| COL1A1 | Collagen type I alpha 1 chain |
| COL3A1 | Collagen type III alpha 1 chain |
| COL4A1 | Collagen type IV alpha 1 chain |
| COL6A1 | Collagen type VI alpha 1 chain |
| DAPI | 4′,6-diamidino-2-phenylindole dihydrochloride |
| DFUs | Diabetic foot ulcers |
| DM | Diabetes mellitus |
| ECM | Extracellular matrix |
| EGF | Epidermal growth factor |
| GLP-1 RAs | Glucagon-like peptide-1 receptor agonists |
| GLP-1 | Glucagon-like peptide-1 |
| GLP-1R | Glucagon-like peptide 1 receptor |
| GPX1 | Glutathione peroxidase-1 |
| GPX4 | Glutathione peroxidase-4 |
| H2O2 | Hydrogen peroxide |
| IL1B | Interleukin-1 beta |
| IL2 | Interleukin-2 |
| MMP3 | Matrix metallopeptidase 3 |
| NHDF | Normal human dermal fibroblasts |
| NHEK | Normal human epidermal keratinocytes |
| PBS | Phosphate-buffered saline |
| PI | Propidium iodide |
| RAGE | Receptor for advanced glycation end-products |
| ROS | Reactive oxygen species |
| RT-qPCR | Quantitative real-time polymerase chain reaction |
| SD | Standard deviation |
| SDS | Sodium dodecyl sulfate |
| SOD1 | Superoxide dismutase 1 |
| T2D | Type 2 diabetes |